European Patent Office

T 2278/14 (Immunoreactive gp19/RESEARCH DEVELOPMENT FOUNDATION) of 22.01.2019

European Case Law Identifier
ECLI:EP:BA:2019:T227814.20190122
Date of decision
22 January 2019
Case number
T 2278/14
Petition for review of
-
Application number
07873953.9
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Immunoreactive Glycoprotein gp19 of Ehrlichia Canis
Applicant name
Research Development Foundation
Opponent name
Macquet, Christophe
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention R 76(2)(c)
Keywords
-
Catchword
-
Cited cases
G 0009/91
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the order to maintain the patent with the following claims and a description to be adapted thereto:

Claims: 1-13 of the main request, received during oral

proceedings of 22 January 2019.